Original ArticlePhysician Preferences for Management of Patients with Stage IIIA NSCLC: Impact of Bulk of Nodal Disease on Therapy Selection
Under an Elsevier user license
open archive
Key Words
Non-small cell lung cancer
Bulky 3A disease
Treatment preferences
Cited by (0)
Disclosure: The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCRR.
Copyright © 2012 International Association for the Study of Lung Cancer. All rights reserved.